Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | KF-0210 |
Trade Name | |
Synonyms | KF0210|KF 0210 |
Drug Descriptions |
KF-0210 is an antagonist of the prostaglandin E2 receptor 4 (EP4), which potentially enhances anti-tumor immune response and tumor growth inhibition (Cancer Res (2023) 83 (7_Supplement): 2330). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Atezolizumab + KF-0210 | Atezolizumab KF-0210 | 0 | 1 |
KF-0210 | KF-0210 | 0 | 1 |